ILLUMINA INC.
Company Snapshot
Company Overview
Incorporated in April 1998, Illumina Inc. is a global life science company that develops and markets genetic analysis solutions for areas such as sequencing, genotyping, and expression. Illumina offers solutions for Multiomics, CNV, DNA methylation analysis, genome sequencing and gene expression profiling. The company operates through two major segments: Life Sciences and Diagnostics. Illumina’s Life Sciences unit offers products and services based on DNA sequencing, gene expression analysis, and real-time PCR to meet the demands of researchers in life science. The Diagnostics unit focuses on products and services in the area of molecular diagnostics, such as HiScan and iScan.
Illumina’s clientele includes genomic research institutes, clinical research organizations, governmental laboratories, and pharmaceutical and biotechnology companies. Illumina is currently headquartered in San Diego, California, and has sales offices and distributors located worldwide. The company operates under two reportable segments: Core Illumina and GRAIL.
Financial Highlights (FY 2024)
This information is available for BCC Research members only.
Company's Business Segments
- Core Illumina : Research, clinical and applied markets, and genomic solutions
- GRAIL : Healthcare company focused on early detection of multiple cancers.
Applications/End User Industries
- Next-Generation Sequencing (NGS)
- Cutting-Edge Array Scanners
- In Vitro Diagnostic (IVD)
- Reagents
- Microarray Kits
- Genotyping
- Epigenetic Analysis
- Vitro Diagnostic
- Oncology Comprehensive
- Sequencing Platform Comparison
- Designstudio Software
- Trusight Oncology
- Basespace Sequence Hub
- Dragen Secondary Analysis
- Illumina Connected Analytics
- Genomic Insights
- Oncology Clinical Research
- Laboratory Information Management System
- Correlation Engine
- Microarray Data Analysis
- DNA Prep Portfolio
- Life Sciences
